RNF122 promotes glioblastoma growth via the JAK2/STAT3/c-Myc signaling Axis.

Qingbao XiaoKaming XueLin LiKai ZhuRong FuZhiyong Xiong

Published in: CNS neuroscience & therapeutics (2024)

Our results revealed that RNF122 caused an aggressive phenotype to GBM and was a poor prognosticator; thus, targeting RNF122 may be effectual in GBM treatment.

Keyphrases

dna damage response
single cell
cancer therapy
drug delivery
oxidative stress
dna damage
dna repair
smoking cessation